Top Story

Fenofibrate slows diabetic retinopathy progression in at-risk patients

September 2, 2014

Intensive treatment of glycemia and dyslipidemia slowed the progression of diabetic retinopathy in diabetic patients with cardiovascular disease or associated risk factors, according to study findings.

Data were culled from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study, a collection of three randomized clinical trials designed to evaluate the effects of intensive blood glucose and blood pressure control and a combination of fenofibrate and statin vs. statin monotherapy therapy for dyslipidemia on the incidence of cardiovascular disease in patients with type 2 diabetes.

In the Journals

Obese teens with high leptin levels have increased brain response to food cues

September 2, 2014
In adolescents, obesity and high circulating leptin levels appear to be significantly associated with increased neural responses to images of high-calorie foods…
In the Journals

Diabetes rates surged along with obesity, but BMI doesn't explain higher incidence in men

September 2, 2014
The rise in diabetes rates in the United States over the past several decades has been strongly influenced by the rise in obesity, according to research published in…
Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according to an Allergan press…
More News Headlines »
CME

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

7/23/2014
Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
figure

Video: Ardis Hoven, MD, explains which changes to the ACA will help physicians most

August 8, 2014
After speaking in an expert panel at the American Association of Diabetes Educators Annual Meeting, Ardis Hoven
More »
CME

Personalized Medicine in Obesity Treatment: An In-depth Look at How to Use Today's Obesity Medications in Patients Who Need to Lose Weight

This activity is supported by an educational grant from Vivus.

4/14/2014
Obesity has increased dramatically in the past 20 years, and is considered a health care epidemic in the United States…
More »